Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick ...
DnD’s journey from tabletop to screen has been a long and varied one, and in all that time 2002’s Neverwinter Nights remains a classic. BioWare’s foray into the Forgotten Realms is still ...
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...
At first blush, the app comes off as immediately handsome, with 3D-rendered miniatures, terrain, and lighting all powered by Unreal Engine 5. In motion, it capably evokes scenes from Baldur’s ...
The company is reducing the cost of its 2.5 milligram and 5 milligram Zepbound vials to $349 and $499 a month, respectively, according to a statement . That’s about $50 less than current prices.
(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online to try to stave off competition from ...
The Florida resort will debut a new generation of wands Saturday that look and feel closer to the real thing when casting spells throughout the Wizarding World of Harry Potter, a popular activity ...
The Indiana-based drugmaker is slashing the prices of its 2.5 mg single-dose vials to $349 per month and bringing its 5 mg single-dose vials down to $499 per month, it said in a Tuesday press release.
Lilly said patients must refill their prescriptions of the two higher-dose vials within 45 days of their first fill to get the same pricing, and would otherwise have to pay as much as $699 for ...
Colombo, March 17 (Daily Mirror) - The Vehicle Importers Association of Lanka (VIAL) claimed today that around 400 vehicles have been stuck at the Sri Lanka Customs for over 20 days due to a ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results